Natural Product: NPC239098
Natural Product ID:   | NPC239098 |
Common Name*:   | Isocupressic Acid |
IUPAC Name:   | (1S,4aR,5S,8aR)-5-[(E)-5-hydroxy-3-methylpent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid |
Synonyms:   | Isocupressic Acid; Isocupressicacid |
Standard InCHIKey:   | DOYKMKZYLAAOGH-DOEMEAPXSA-N |
Standard InCHI:   | InChI=1S/C20H32O3/c1-14(10-13-21)6-8-16-15(2)7-9-17-19(16,3)11-5-12-20(17,4)18(22)23/h10,16-17,21H,2,5-9,11-13H2,1,3-4H3,(H,22,23)/b14-10+/t16-,17+,19+,20-/m0/s1 |
SMILES:   | C/C(=CCO)/CC[C@H]1C(=C)CC[C@@H]2[C@]1(C)CCC[C@]2(C)C(=O)O
|
Synthetic Gene Cluster:   |
n.a. |
ChEMBL Identifier:   |
CHEMBL511193 |
PubChem CID:   |
6438138 |
Chemical Classification**:   |
-
CHEMONTID:0000000 [Organic compounds]
-
[CHEMONTID:0000012] Lipids and lipid-like molecules
-
[CHEMONTID:0000259] Prenol lipids
[CHEMONTID:0001551] Diterpenoids
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
  Species Source
Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
NPO30782 |
Brazilian propolis |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
DOI[10.1248/cpb.47.1521] |
NPO30782 |
Brazilian propolis |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
PMID[11000036] |
NPO28256 |
Platycladus orientalis |
Species |
Cupressaceae |
Eukaryota |
Leaves and branches |
Soorkesh Valley, Gollestan, Iran |
n.a. |
PMID[15104493] |
NPO28256 |
Platycladus orientalis |
Species |
Cupressaceae |
Eukaryota |
leaves |
Soorkesh Valley, Gollestan, Iran |
n.a. |
PMID[15104493] |
NPO13135 |
Campylotropis hirtella |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[19481938] |
NPO32847 |
fokienia hodginsii |
Species |
Cupressaceae |
Eukaryota |
Twigs and Leaves |
n.a. |
n.a. |
PMID[23691952] |
NPO12796 |
Periploca sepium |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[28294615] |
NPO865 |
Dendrobium loddigesii |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[31291099] |
NPO18636 |
Cupressus macrocarpa |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[32223924] |
NPO30782 |
Brazilian propolis |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
PMID[8951168] |
NPO30782 |
Brazilian propolis |
n.a. |
n.a. |
n.a. |
n.a. |
Brazilian propolis |
n.a. |
PMID[9677271] |
NPO7773 |
Crinum moorei |
Species |
Amaryllidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO865 |
Dendrobium loddigesii |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO6731 |
Ononis spinosa |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO12796 |
Periploca sepium |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO17259 |
Thuja standishii |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO13135 |
Campylotropis hirtella |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO17259 |
Thuja standishii |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO12796 |
Periploca sepium |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO13135 |
Campylotropis hirtella |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO28256 |
Platycladus orientalis |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO18636 |
Cupressus macrocarpa |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO6731 |
Ononis spinosa |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO7773 |
Crinum moorei |
Species |
Amaryllidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO865 |
Dendrobium loddigesii |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO28256 |
Platycladus orientalis |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO865 |
Dendrobium loddigesii |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO12796 |
Periploca sepium |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO6731 |
Ononis spinosa |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO865 |
Dendrobium loddigesii |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO12796 |
Periploca sepium |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO28256 |
Platycladus orientalis |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO865 |
Dendrobium loddigesii |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO22691 |
Mentha cardiaca |
Species |
Lamiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO1257 |
Distephanus angulifolius |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO10638 |
Plectranthus myrianthus |
Species |
Lamiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO12796 |
Periploca sepium |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO3873 |
Crotalaria candicans |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO11843 |
Stephania zippeliana |
Species |
Menispermaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO9319 |
Pterocaulon virgatum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO12565 |
Hypericum polyanthemum |
Species |
Hypericaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21720 |
Talaromyces variabilis |
Species |
Trichocomaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO7822.1 |
Eucalyptus globulus subsp. bicostata |
Subspecies |
Myrtaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO11190 |
Veronica polita |
Species |
Plantaginaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO10922 |
Pentaclethra macrophylla |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO28256 |
Platycladus orientalis |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO5043 |
Eria japonica |
Species |
Orchidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO12091 |
Martensia denticulata |
Species |
Delesseriaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO8934 |
Gypsophila perfoliata |
Species |
Caryophyllaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO526 |
Salvia sessei |
Species |
Lamiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO9532 |
Vernonia cistifolia |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO6731 |
Ononis spinosa |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO17259 |
Thuja standishii |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO18636 |
Cupressus macrocarpa |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO13135 |
Campylotropis hirtella |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO1815 |
Breonia chinensis |
Species |
Rubiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO12205 |
Eucalyptus apodophylla |
Species |
Myrtaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO6289 |
Ceropegia dichotoma |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO9704 |
Sonneratia caseolaris |
Species |
Lythraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO11576 |
Glycosmis macrophylla |
Species |
Rutaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO5456 |
Juniperus drupacea |
Species |
Cupressaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO23384 |
Rhodiola semenovii |
Species |
Crassulaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO10605 |
Tristania conferta |
Species |
Myrtaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO7773 |
Crinum moorei |
Species |
Amaryllidaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration
Organism ID |
NP ID |
Organism Material Preparation |
Organism Part |
NP Quantity (Standard) |
NP Quantity (Minimum) |
NP Quantity (Maximum) |
Quantity Unit |
Reference |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  Biological Activity
Activity Type |
# Activity |
ED50 |
2 |
IC50 |
7 |
Others |
2 |
Activity Type |
# Activity |
Cell Line |
9 |
NON-MOLECULAR |
1 |
Organism |
1 |
Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT453 |
Cell Line |
HT-1080 |
Homo sapiens |
ED50 |
= |
72.91 |
ug ml-1 |
PMID[547009] |
NPT660 |
Cell Line |
SW480 |
Homo sapiens |
IC50 |
> |
40000.0 |
nM |
PMID[547011] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
> |
40000.0 |
nM |
PMID[547011] |
NPT81 |
Cell Line |
A549 |
Homo sapiens |
IC50 |
> |
40000.0 |
nM |
PMID[547011] |
NPT659 |
Cell Line |
SMMC-7721 |
Homo sapiens |
IC50 |
> |
40000.0 |
nM |
PMID[547011] |
NPT116 |
Cell Line |
HL-60 |
Homo sapiens |
IC50 |
> |
40000.0 |
nM |
PMID[547011] |
NPT2740 |
Cell Line |
Neutrophils |
|
IC50 |
= |
4800.0 |
nM |
PMID[547012] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
78.0 |
% |
PMID[547012] |
NPT2740 |
Cell Line |
Neutrophils |
|
Inhibition |
= |
19.9 |
% |
PMID[547012] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
ED50 |
= |
63.54 |
ug ml-1 |
PMID[547009] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
104500.0 |
nM |
PMID[547010] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
  Chemically structural similarity: I. Similar Active Natural Products in NPASS
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient ![](images/questionmark.png)
●  The left chart: Distribution of similarity level between NPC239098 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 161 |
0.1-0.2 | 993 |
0.2-0.3 | 4664 |
0.3-0.4 | 14390 |
0.4-0.5 | 9290 |
0.5-0.6 | 6668 |
0.6-0.7 | 4629 |
0.7-0.8 | 1675 |
0.8-0.85 | 166 |
0.85-0.9 | 48 |
0.9-0.95 | 12 |
0.95-1 | 1 |
  Chemically structural similarity: II. Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC239098 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 144 |
0.1-0.2 | 1384 |
0.2-0.3 | 3765 |
0.3-0.4 | 2515 |
0.4-0.5 | 803 |
0.5-0.6 | 258 |
0.6-0.7 | 240 |
0.7-0.8 | 40 |
0.8-0.85 | 1 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8049 |
Intermediate Similarity |
NPD4752 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD4786 |
Approved |
0.7841 |
Intermediate Similarity |
NPD7515 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD3667 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5784 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD3133 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3665 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD3666 |
Approved |
0.7558 |
Intermediate Similarity |
NPD7520 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD6399 |
Phase 3 |
0.7473 |
Intermediate Similarity |
NPD7748 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4623 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7146 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7334 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4519 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7521 |
Approved |
0.7471 |
Intermediate Similarity |
NPD6409 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5330 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3618 |
Phase 1 |
0.7471 |
Intermediate Similarity |
NPD6684 |
Approved |
0.7447 |
Intermediate Similarity |
NPD7640 |
Approved |
0.7447 |
Intermediate Similarity |
NPD7639 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6083 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD6084 |
Phase 2 |
0.7416 |
Intermediate Similarity |
NPD5328 |
Approved |
0.7407 |
Intermediate Similarity |
NPD8039 |
Approved |
0.7381 |
Intermediate Similarity |
NPD4695 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD5779 |
Approved |
0.7363 |
Intermediate Similarity |
NPD5778 |
Approved |
0.734 |
Intermediate Similarity |
NPD7638 |
Approved |
0.7326 |
Intermediate Similarity |
NPD5362 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD5737 |
Approved |
0.7303 |
Intermediate Similarity |
NPD7513 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD6672 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6903 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5279 |
Phase 3 |
0.7253 |
Intermediate Similarity |
NPD6411 |
Approved |
0.7253 |
Intermediate Similarity |
NPD7637 |
Suspended |
0.7253 |
Intermediate Similarity |
NPD6079 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7902 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7285 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4753 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD4221 |
Approved |
0.7209 |
Intermediate Similarity |
NPD4269 |
Approved |
0.7209 |
Intermediate Similarity |
NPD4270 |
Approved |
0.7209 |
Intermediate Similarity |
NPD4223 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD5329 |
Approved |
0.7158 |
Intermediate Similarity |
NPD4225 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4788 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7154 |
Phase 3 |
0.71 |
Intermediate Similarity |
NPD6686 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6404 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD6098 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6926 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6924 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6929 |
Approved |
0.7045 |
Intermediate Similarity |
NPD4197 |
Approved |
0.7045 |
Intermediate Similarity |
NPD3668 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD6101 |
Approved |
0.7033 |
Intermediate Similarity |
NPD5764 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD5695 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD4202 |
Approved |
0.6988 |
Remote Similarity |
NPD6942 |
Approved |
0.6988 |
Remote Similarity |
NPD7339 |
Approved |
0.6988 |
Remote Similarity |
NPD8264 |
Approved |
0.6979 |
Remote Similarity |
NPD5696 |
Approved |
0.6977 |
Remote Similarity |
NPD4819 |
Approved |
0.6977 |
Remote Similarity |
NPD4252 |
Approved |
0.6977 |
Remote Similarity |
NPD6930 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD4822 |
Approved |
0.6977 |
Remote Similarity |
NPD6931 |
Approved |
0.6977 |
Remote Similarity |
NPD4821 |
Approved |
0.6977 |
Remote Similarity |
NPD4820 |
Approved |
0.6966 |
Remote Similarity |
NPD5363 |
Approved |
0.6957 |
Remote Similarity |
NPD5785 |
Approved |
0.6941 |
Remote Similarity |
NPD3617 |
Approved |
0.6941 |
Remote Similarity |
NPD4271 |
Approved |
0.6941 |
Remote Similarity |
NPD7322 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD4268 |
Approved |
0.6932 |
Remote Similarity |
NPD5332 |
Approved |
0.6932 |
Remote Similarity |
NPD5331 |
Approved |
0.6915 |
Remote Similarity |
NPD7900 |
Approved |
0.6915 |
Remote Similarity |
NPD7901 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD6933 |
Approved |
0.6905 |
Remote Similarity |
NPD3701 |
Clinical (unspecified phase) |
0.69 |
Remote Similarity |
NPD6402 |
Approved |
0.69 |
Remote Similarity |
NPD5739 |
Approved |
0.69 |
Remote Similarity |
NPD7128 |
Approved |
0.69 |
Remote Similarity |
NPD6675 |
Approved |
0.6897 |
Remote Similarity |
NPD4790 |
Discontinued |
0.6889 |
Remote Similarity |
NPD4693 |
Phase 3 |
0.6889 |
Remote Similarity |
NPD4689 |
Approved |
0.6889 |
Remote Similarity |
NPD4688 |
Approved |
0.6889 |
Remote Similarity |
NPD5786 |
Approved |
0.6889 |
Remote Similarity |
NPD4138 |
Approved |
0.6889 |
Remote Similarity |
NPD5205 |
Approved |
0.6889 |
Remote Similarity |
NPD4690 |
Approved |
0.6882 |
Remote Similarity |
NPD8035 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD5281 |
Approved |
0.6882 |
Remote Similarity |
NPD8034 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD5284 |
Approved |
0.6867 |
Remote Similarity |
NPD6113 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7645 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD6673 |
Approved |
0.6848 |
Remote Similarity |
NPD6904 |
Approved |
0.6848 |
Remote Similarity |
NPD6080 |
Approved |
0.6842 |
Remote Similarity |
NPD4629 |
Approved |
0.6842 |
Remote Similarity |
NPD5210 |
Approved |
0.6824 |
Remote Similarity |
NPD5776 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD6925 |
Approved |
0.6813 |
Remote Similarity |
NPD3573 |
Approved |
0.679 |
Remote Similarity |
NPD6923 |
Approved |
0.679 |
Remote Similarity |
NPD6922 |
Approved |
0.6782 |
Remote Similarity |
NPD7332 |
Phase 2 |
0.6782 |
Remote Similarity |
NPD7514 |
Phase 3 |
0.6782 |
Remote Similarity |
NPD5368 |
Approved |
0.6782 |
Remote Similarity |
NPD5790 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD7525 |
Registered |
0.6778 |
Remote Similarity |
NPD1694 |
Approved |
0.6771 |
Remote Similarity |
NPD7614 |
Phase 1 |
0.6771 |
Remote Similarity |
NPD4697 |
Phase 3 |
0.6771 |
Remote Similarity |
NPD5220 |
Clinical (unspecified phase) |
0.6771 |
Remote Similarity |
NPD5221 |
Approved |
0.6771 |
Remote Similarity |
NPD5222 |
Approved |
0.6768 |
Remote Similarity |
NPD7632 |
Discontinued |
0.6768 |
Remote Similarity |
NPD5211 |
Phase 2 |
0.6765 |
Remote Similarity |
NPD7320 |
Approved |
0.6765 |
Remote Similarity |
NPD6881 |
Approved |
0.6765 |
Remote Similarity |
NPD6899 |
Approved |
0.6744 |
Remote Similarity |
NPD7145 |
Approved |
0.6742 |
Remote Similarity |
NPD6695 |
Phase 3 |
0.6739 |
Remote Similarity |
NPD5208 |
Approved |
0.6729 |
Remote Similarity |
NPD7115 |
Discovery |
0.6712 |
Remote Similarity |
NPD4266 |
Approved |
0.6712 |
Remote Similarity |
NPD3196 |
Approved |
0.6712 |
Remote Similarity |
NPD3194 |
Approved |
0.6712 |
Remote Similarity |
NPD3195 |
Phase 2 |
0.6709 |
Remote Similarity |
NPD3171 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD7144 |
Approved |
0.6707 |
Remote Similarity |
NPD7143 |
Approved |
0.6706 |
Remote Similarity |
NPD6117 |
Approved |
0.6705 |
Remote Similarity |
NPD5369 |
Approved |
0.6705 |
Remote Similarity |
NPD6902 |
Approved |
0.6703 |
Remote Similarity |
NPD3574 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD5280 |
Approved |
0.6703 |
Remote Similarity |
NPD5690 |
Phase 2 |
0.6703 |
Remote Similarity |
NPD4694 |
Approved |
0.6702 |
Remote Similarity |
NPD5693 |
Phase 1 |
0.6701 |
Remote Similarity |
NPD5173 |
Approved |
0.6701 |
Remote Similarity |
NPD4755 |
Approved |
0.6699 |
Remote Similarity |
NPD6373 |
Approved |
0.6699 |
Remote Similarity |
NPD6372 |
Approved |
0.6667 |
Remote Similarity |
NPD7338 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6356 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6051 |
Approved |
0.6667 |
Remote Similarity |
NPD5701 |
Approved |
0.6667 |
Remote Similarity |
NPD5697 |
Approved |
0.6635 |
Remote Similarity |
NPD6883 |
Approved |
0.6635 |
Remote Similarity |
NPD7102 |
Approved |
0.6635 |
Remote Similarity |
NPD7290 |
Approved |
0.6634 |
Remote Similarity |
NPD5141 |
Approved |
0.663 |
Remote Similarity |
NPD4751 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD6435 |
Approved |
0.6628 |
Remote Similarity |
NPD6116 |
Phase 1 |
0.6627 |
Remote Similarity |
NPD7152 |
Approved |
0.6627 |
Remote Similarity |
NPD4243 |
Approved |
0.6627 |
Remote Similarity |
NPD7151 |
Approved |
0.6627 |
Remote Similarity |
NPD7150 |
Approved |
0.6625 |
Remote Similarity |
NPD7331 |
Phase 2 |
0.6625 |
Remote Similarity |
NPD4224 |
Phase 2 |
0.6623 |
Remote Similarity |
NPD4246 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD342 |
Phase 1 |
0.6602 |
Remote Similarity |
NPD6011 |
Approved |
0.6596 |
Remote Similarity |
NPD46 |
Approved |
0.6596 |
Remote Similarity |
NPD6698 |
Approved |
0.6593 |
Remote Similarity |
NPD6893 |
Approved |
0.6591 |
Remote Similarity |
NPD7509 |
Discontinued |
0.6585 |
Remote Similarity |
NPD4137 |
Phase 3 |
0.6582 |
Remote Similarity |
NPD3197 |
Phase 1 |
0.6575 |
Remote Similarity |
NPD3172 |
Approved |
0.6571 |
Remote Similarity |
NPD6401 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD6617 |
Approved |
0.6571 |
Remote Similarity |
NPD6649 |
Approved |
0.6571 |
Remote Similarity |
NPD6869 |
Approved |
0.6571 |
Remote Similarity |
NPD8130 |
Phase 1 |
0.6571 |
Remote Similarity |
NPD6650 |
Approved |
0.6571 |
Remote Similarity |
NPD6847 |
Approved |
0.6566 |
Remote Similarity |
NPD5285 |
Approved |
0.6566 |
Remote Similarity |
NPD5286 |
Approved |
0.6566 |
Remote Similarity |
NPD4700 |
Approved |
0.6566 |
Remote Similarity |
NPD4696 |
Approved |
0.6552 |
Remote Similarity |
NPD6115 |
Approved |
0.6552 |
Remote Similarity |
NPD6114 |
Approved |
0.6552 |
Remote Similarity |
NPD6697 |
Approved |
0.6552 |
Remote Similarity |
NPD6118 |
Approved |
0.6538 |
Remote Similarity |
NPD6012 |
Approved |
0.6538 |
Remote Similarity |
NPD4194 |
Approved |
0.6538 |
Remote Similarity |
NPD6014 |
Approved |
0.6538 |
Remote Similarity |
NPD4191 |
Approved |
0.6538
|
Remote Similarity |
NPD6013 |
Approved |